Citius Pharmaceuticals Inc (CTXR)
0.3454
-0.01
(-3.76%)
USD |
NASDAQ |
Nov 04, 16:00
0.346
0.00 (0.00%)
After-Hours: 20:00
Citius Pharmaceuticals Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | 0.00 |
September 30, 2021 | -40.00M |
June 30, 2021 | -0.0069M |
March 31, 2021 | |
December 31, 2020 | |
September 30, 2020 | 0.00 |
June 30, 2020 | -0.0018M |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | 0.00 |
Date | Value |
---|---|
June 30, 2016 | 0.00 |
March 31, 2016 | 0.2557M |
December 31, 2015 | |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
March 31, 2011 | 0.00 |
December 31, 2010 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-40.00M
Minimum
Sep 2021
--
Maximum
Sep 2020
-8.002M
Average
-0.0018M
Median
Jun 2020
Cash from Investing (Quarterly) Benchmarks
Agilent Technologies Inc | -100.00M |
Seelos Therapeutics Inc | -- |
Cara Therapeutics Inc | 15.29M |
Moleculin Biotech Inc | -0.013M |
Citius Oncology Inc | -- |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -8.367M |
Cash from Financing (Quarterly) | 13.72M |
Free Cash Flow | -29.09M |
Free Cash Flow Per Share (Quarterly) | -0.0481 |
Free Cash Flow Yield | -51.76% |